Phage Display Library Screening Strategy Introduction

Phage display technology is a technique for efficient gene expression screening. It mainly involves the fusion of exogenous proteins or peptides with specific phage coat proteins, which are displayed on the phage surface and maintain relatively independent spatial conformation and biological activity. This technology facilitates the specific recognition and binding of target molecules, thus realizing the unification of genotype and expression. The two core elements of phage display technology are phage library construction and phage library screening. Phage library screening mainly includes two main steps, namely panning and characterization. Currently, the commonly used phage display library screening strategies include solid-phase panning, liquid-phase panning, cell panning, tissue panning, in vivo panning, selective infection, and automated panning. Based on our rich field experience and advanced research platform, Creative Biolabs provides comprehensive services to support antibody library screening.

Laboratory mice. (Creative Biolabs Authorized)

In Vivo Phage Display Screening

In vivo screening involves the intravenous injection of phage display libraries into animals. Because of the heterogeneity of the endothelium for vascular molecules, phages can be selectively directed to different tissues. This results in phage display antibodies that bind specifically to different tissues.

Ex Vivo Phage Display Screening

There are different methods for ex vivo screening, such as bio-biopanning, competition, abatement, selective infection screening, and delayed infection screening. Among these methods, bio-biopanning is the most commonly used. The bio-biopanning method uses the target protein as the stationary phase and the phage display library as the mobile phase. After a period of co-incubation, the free phage that has not been combined will be washed away, and then the phage that has been combined and adsorbed with the target molecule will be eluted by the competing receptor or acid, and the eluted phage will be infected with the host cell, then propagated and amplified, and then the next round of biopanning will be carried out, and the antibody that has a high affinity with the target protein can be obtained after 3 to 5 rounds of adsorption-biopanning-amplification.

Therapeutic Antibody Discovery

Phage display technology has unique advantages in the field of antibody discovery. On the one hand, the process of antibody development by phage display technology does not require immunization and is simple and fast. When developing antibodies using phage display technology, the screening process can be better controlled, and antibodies can even be produced against targets that are not immunogenic. In addition, phage display technology can utilize bacterial expression systems for antibody development.

Premade antibody libraries also play an important role in the antibody development process. It can be used for B-cell and T-cell epitope mapping as well as for the selection of biologically active peptides that bind to receptors or proteins, disease-specific antigen mimics, peptides that bind to non-protein targets, cell-specific peptides, or organ-specific peptides. In addition, preformed antibody libraries have a wide range of applications in areas such as peptide-mediated drug delivery systems.

More Details on Phage Display Library Screening Strategies

In Vivo Screening Introduction
Ex Vivo Screening Introduction
Solid-Phase Screening Introduction
Solution-Sorting Screening Introduction
Cell-Based Screening Introduction
Protease Substrate Screening Introduction
Premade Phage Display Antibody Library Screening Introduction
Premade Phage Display Peptide Library Screening Introduction

Creative Biolabs has a wealth of knowledge and experience in phage display library screening. We are happy to share our knowledge and experience in the field of phage display library screening with you.

All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.

Online Inquiry

	USA: Europe: Germany:
	Call us at: USA: UK: Germany:
	Fax:
	Email: